In randomized controlled trials, there are two treatment selections currently regarded the regular of care in Guillain-Barré syndrome (GBS). These involve both intravenous immunoglobulin (IVIG) or plasma exchange. https://zoyakqdn847122.ka-blogs.com/83772053/fascination-about-gbs-treatment